You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 10,226,458


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,226,458
Title:Pharmaceutical compositions comprising sorbitan esters
Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
Inventor(s): Perry; Jason M. (Cambridge, MA), Deaver; Daniel R. (Franklin, MA), Hickey; Magali B. (Westwood, MA), Remenar; Julius F. (Framingham, MA), Vandiver; Jennifer (Arlington, MA)
Assignee: ALKERMES PHARMA IRELAND LIMITED (Dublin, IE)
Application Number:15/388,554
Patent Claims: 1. A method for treating schizophrenia, bipolar disorder, or depression in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising: (a) compound A-7: ##STR00017## (b) sorbitan laurate; (c) polysorbate 20; and (d) an aqueous vehicle, wherein the composition forms an aqueous, flocculated, injectable suspension.

2. The method of claim 1, wherein depression is treated.

3. The method of claim 1, wherein bipolar disorder is treated.

4. The method of claim 1, wherein schizophrenia is treated.

5. The method of claim 1, wherein the ratio of components (b) to (c) is approximately 5 to 2, by weight.

6. The method of claim 1, comprising about 0.2- 1 weight percent sorbitan laurate.

7. The method of claim 1, comprising about 0.4- 0.7 weight percent sorbitan laurate.

8. The method of claim 1, comprising about 0.5 weight percent sorbitan laurate.

9. The method of claim 1, comprising about 0.05- 0.8 weight percent polysorbate 20.

10. The method of claim 1, comprising about 0.1- 0.3 weight percent polysorbate 20.

11. The method of claim 1, comprising about 0.2 weight percent polysorbate 20.

12. The method of claim 1, comprising approximately 15- 35 weight percent compound A-7.

13. The method of claim 1, comprising approximately 20- 30 weight percent compound A-7.

14. A method for treating schizophrenia, bipolar disorder, or depression in a subject in need thereof comprising administering to the subject an injectable pharmaceutical composition comprising: (a) 15-35 weight percent compound A-7: ##STR00018## (b) approximately 0.2-1 weight percent sorbitan laurate; (c) approximately 0.05-0.8 weight percent polysorbate 20; and (d) an aqueous carrier.

15. The method of claim 14, wherein schizophrenia is treated.

16. A method for treating schizophrenia, bipolar disorder, or depression in a subject in need thereof comprising administering to the subject an injectable composition comprising: (a) compound A-7: ##STR00019## (b) sorbitan laurate; (c) polysorbate 20; and (d) an aqueous vehicle.

17. The method of claim 16, wherein the composition further comprises a buffer.

18. The method of claim 17, wherein the buffer is a phosphate, citrate, tartrate or acetate buffer.

19. The method of claim 16, wherein schizophrenia is treated.

20. A method for treating schizophrenia, bipolar disorder, or depression in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising: (a) 24-30 weight percent compound A-7: ##STR00020## (b) 0.2-1 weight percent sorbitan laurate; (c) 0.1-0.3 weight percent polysorbate 20; and (d) an aqueous vehicle.

21. The method of claim 20, wherein schizophrenia is treated.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.